Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MSCI Inc.MSCI · Entity 3075 | Principal Accounting Officer | May 07, 2018 | May 08, 2018 |
| Teladoc Health, Inc.TDOC · Entity 1547 | CHIEF ACCOUNTING OFFICER | March 19, 2024 | March 20, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MSCI Inc.
Report date May 07, 2018 · Filed May 08, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,963 |
Reported balance
After 2018-05-07 transaction · row 1
1 source rowRow 1 · 2018-05-07 · Sale · Disposed 3,362 · Balance 6,963 |
Teladoc Health, Inc.
Report date March 19, 2024 · Filed March 20, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 37,500 |
Reported balance
After 2024-03-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-03-19 · Grant · Acquired 37,500 · Balance 37,500 F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F2: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2023 Filed Mar 3, 2023 21:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,259 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004083 · form4-03032023_090302.xml · nonDerivative · entry 2 Napolitano Richard J · CIK 0001599417 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:12 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 1,347 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-004083 · form4-03032023_090302.xml · nonDerivative · entry 1 Napolitano Richard J · CIK 0001599417 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,155 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 787 | $33.00 | $25,973.36 |
DisclosureSEC source: 0001415889-23-001923 · form4-02032023_090216.xml · nonDerivative · entry 2 Napolitano Richard J · CIK 0001599417 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,808 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 2,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-001923 · form4-02032023_090216.xml · derivative · entry 3 Napolitano Richard J · CIK 0001599417 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,020 Underlying: Common Stock · 2,019 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On February 1, 2021, the reporting person was granted 6,058 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On February 1, 2021, the reporting person was granted 6,058 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 21:09 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,019 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-23-001923 · form4-02032023_090216.xml · nonDerivative · entry 1 Napolitano Richard J · CIK 0001599417 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| September 23, 2022 Filed Sep 26, 2022 20:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 220 | $27.65 | $6,083.88 |
DisclosureSEC source: 0001415889-22-009946 · form4-09262022_010907.xml · nonDerivative · entry 2 Napolitano Richard J · CIK 0001599417 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,576 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 20:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 601 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-009946 · form4-09262022_010907.xml · derivative · entry 3 Napolitano Richard J · CIK 0001599417 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,202 Underlying: Common Stock · 601 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On September 22, 2021, the reporting person was granted 1,803 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On September 22, 2021, the reporting person was granted 1,803 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 20:11 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 601 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-009946 · form4-09262022_010907.xml · nonDerivative · entry 1 Napolitano Richard J · CIK 0001599417 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 10,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-006087 · form4-06032022_010641.xml · derivative · entry 2 Napolitano Richard J · CIK 0001599417 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,730 Underlying: Common Stock · 10,730 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F3 · derivative.exercise_date: One-third of the restricted stock units vest on June 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: One-third of the restricted stock units vest on June 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantEmployee Stock Option (right to buy) · Derivative | 25,866 | $0.00 Strike: $32.62 | $0.00 |
DisclosureSEC source: 0001415889-22-006087 · form4-06032022_010641.xml · derivative · entry 1 Napolitano Richard J · CIK 0001599417 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,866 Underlying: Common Stock · 25,866 shares Expires 2032-05-31 F1 · derivative.exercise_date: The option will vest as to one-third of the shares on June 1, 2023. The remainder of the shares will vest in 24 substantially equal monthly installments thereafter. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 20:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 6,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-003705 · form4-04042022_010406.xml · derivative · entry 1 Napolitano Richard J · CIK 0001599417 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,778 Underlying: Common Stock · 6,778 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on March 1, 2022, with the remainder vesting in eight substantially equal quarterly installments thereafter. F2 · derivative.expiration_date: One-third of the restricted stock units vest on March 1, 2022, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| April 01, 2022 Filed May 2, 2022 20:12 UTC Amendment | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 6,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004437 · form4a-05022022_010524.xml · derivative · entry 1 Napolitano Richard J · CIK 0001599417 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,778 Underlying: Common Stock · 6,778 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.exercise_date: On April 4, 2022, the reporting person filed a Form 4 which inadvertently reported that the restricted stock units will vest on March 1, 2022, with the remainder vesting in eight substantially equal quarterly installments thereafter, instead of on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter. F2 · derivative.expiration_date: One-third of the restricted stock units vest on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On April 4, 2022, the reporting person filed a Form 4 which inadvertently reported that the restricted stock units will vest on March 1, 2022, with the remainder vesting in eight substantially equal quarterly installments thereafter, instead of on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:31 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 4,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-001912 · edgar.xml · derivative · entry 1 Napolitano Richard J · CIK 0001599417 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,043 Underlying: Common Stock · 4,043 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F2 · derivative.expiration_date: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 02, 2022 Filed Feb 3, 2022 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 824 | $78.66 | $64,813.37 |
DisclosureSEC source: 0001179110-22-000788 · edgar.xml · nonDerivative · entry 2 Napolitano Richard J · CIK 0001599417 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,195 F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 2,019 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000788 · edgar.xml · derivative · entry 3 Napolitano Richard J · CIK 0001599417 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,039 Underlying: Common Stock · 2,019 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F2 · derivative.exercise_date: On February 1, 2021, the reporting person was granted 6,058 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On February 1, 2021, the reporting person was granted 6,058 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 2,019 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-22-000788 · edgar.xml · nonDerivative · entry 1 Napolitano Richard J · CIK 0001599417 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,019 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 20:10 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 1,803 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-008910 · edgar.xml · derivative · entry 1 Napolitano Richard J · CIK 0001599417 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,803 Underlying: Common Stock · 1,803 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock units vest in three substantially equal annual installments beginning September 22, 2022. F2 · derivative.expiration_date: The restricted stock units vest in three substantially equal annual installments beginning September 22, 2022. Read SEC document |
| February 01, 2021 Filed Feb 3, 2021 21:13 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 6,058 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-001194 · edgar.xml · derivative · entry 1 Napolitano Richard J · CIK 0001599417 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,058 Underlying: Common Stock · 6,058 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2 · derivative.exercise_date: The restricted stock unit vests in three equal annual installments beginning February 1, 2022. F2 · derivative.expiration_date: The restricted stock unit vests in three equal annual installments beginning February 1, 2022. Read SEC document |
| May 07, 2018 Filed May 8, 2018 22:05 UTC | MSCI Inc. MSCI · Entity 3075 | SaleCommon Stock | 3,362 | $154.75 | $520,269.50 |
DisclosureSEC source: 0001209191-18-028688 · doc4.xml · nonDerivative · entry 1 Napolitano Richard J · CIK 0001599417 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,963 Read SEC document |
| February 10, 2018 Filed Feb 13, 2018 21:41 UTC | MSCI Inc. MSCI · Entity 3075 | Tax withholdingCommon Stock | 289 | $136.48 | $39,442.72 |
DisclosureSEC source: 0001209191-18-009569 · doc4.xml · nonDerivative · entry 1 Napolitano Richard J · CIK 0001599417 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,325 F1 · shares: Represents shares reacquired by MSCI Inc. to satisfy tax withholding obligations in connection with the vesting and conversion to shares of the second tranche of 589 restricted stock units granted on February 10, 2016. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 21:37 UTC | MSCI Inc. MSCI · Entity 3075 | Tax withholdingCommon Stock | 189 | $139.76 | $26,414.64 |
DisclosureSEC source: 0001209191-18-008852 · doc4.xml · nonDerivative · entry 1 Napolitano Richard J · CIK 0001599417 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,614 F1 · shares: Represents shares reacquired by MSCI Inc. to satisfy tax withholding obligations in connection with the vesting and conversion to shares of the first tranche of 448 restricted stock units granted on February 7, 2017. Read SEC document |
| February 06, 2018 Filed Feb 6, 2018 21:51 UTC | MSCI Inc. MSCI · Entity 3075 | GrantCommon Stock | 1,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007892 · doc4.xml · nonDerivative · entry 3 Napolitano Richard J · CIK 0001599417 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,803 F3 · shares: Restricted stock units ("RSUs") ratably vesting and converting to shares on the first, second and third anniversaries of the grant date. Each RSU represents a contingent right to receive one share of MSCI common stock. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 21:51 UTC | MSCI Inc. MSCI · Entity 3075 | Tax withholdingCommon Stock | 812 | $142.53 | $115,734.36 |
DisclosureSEC source: 0001209191-18-007892 · doc4.xml · nonDerivative · entry 2 Napolitano Richard J · CIK 0001599417 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,790 F2 · shares: Represents shares reacquired by MSCI Inc. to satisfy tax withholding obligations in connection with the vesting and conversion to shares of 1,909 PSUs granted on January 27, 2015. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 21:51 UTC | MSCI Inc. MSCI · Entity 3075 | GrantCommon Stock | 1,909 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-007892 · doc4.xml · nonDerivative · entry 1 Napolitano Richard J · CIK 0001599417 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,602 F1 · shares: Represents the number of shares of common stock issued following the vesting and conversion of performance stock units ("PSUs") granted to the reporting person on January 27, 2015, upon certification by the Compensation and Talent Management Committee of the achievement of certain cumulative performance metrics for the 2015, 2016 and 2017 fiscal years. Read SEC document |
| January 27, 2018 Filed Jan 30, 2018 21:54 UTC | MSCI Inc. MSCI · Entity 3075 | Tax withholdingCommon Stock | 191 | $140.57 | $26,848.87 |
DisclosureSEC source: 0001209191-18-006047 · doc4.xml · nonDerivative · entry 1 Napolitano Richard J · CIK 0001599417 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,693 F1 · shares: Represents shares reacquired by MSCI Inc. to satisfy tax withholding obligations in connection with the vesting and conversion to shares of the third tranche of 402 restricted stock units granted on January 27, 2015. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 22:54 UTC | MSCI Inc. MSCI · Entity 3075 | Tax withholdingCommon Stock | 248 | $91.22 | $22,622.56 |
DisclosureSEC source: 0001209191-17-010700 · doc4.xml · nonDerivative · entry 1 Napolitano Richard J · CIK 0001599417 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,884 F1 · shares: Represents shares reacquired by MSCI Inc. to satisfy tax withholding obligations in connection with the vesting and conversion to shares of 589 restricted stock units granted to the Reporting Person on February 10, 2016. Read SEC document |
| February 07, 2017 Filed Feb 8, 2017 22:39 UTC | MSCI Inc. MSCI · Entity 3075 | GrantCommon Stock | 1,343 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-008834 · doc4.xml · nonDerivative · entry 1 Napolitano Richard J · CIK 0001599417 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,132 F1 · shares: Restricted stock units ("RSUs") vesting and converting to 448, 448 and 447 shares on the first, second and third anniversaries of the grant date, respectively. Each RSU represents a contingent right to receive one share of MSCI common stock. Read SEC document |
| January 28, 2017 Filed Jan 31, 2017 22:44 UTC | MSCI Inc. MSCI · Entity 3075 | Tax withholdingCommon Stock | 288 | $82.76 | $23,834.88 |
DisclosureSEC source: 0001209191-17-006452 · doc4.xml · nonDerivative · entry 2 Napolitano Richard J · CIK 0001599417 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,789 F2 · shares: Represents shares reacquired by MSCI Inc. to satisfy tax withholding obligations in connection with the vesting and conversion to shares of 693 restricted stock units granted to the Reporting Person on January 28, 2014. Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 22:44 UTC | MSCI Inc. MSCI · Entity 3075 | Tax withholdingCommon Stock | 737 | $82.76 | $60,994.12 |
DisclosureSEC source: 0001209191-17-006452 · doc4.xml · nonDerivative · entry 1 Napolitano Richard J · CIK 0001599417 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,077 F1 · shares: Represents shares reacquired by MSCI Inc. to satisfy tax withholding obligations in connection with the vesting and conversion to shares of 1,618 restricted stock units granted to the Reporting Person on January 27, 2015. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 22:23 UTC | MSCI Inc. MSCI · Entity 3075 | Tax withholdingCommon Stock | 254 | $78.78 | $20,010.12 |
DisclosureSEC source: 0001209191-17-001222 · doc4.xml · nonDerivative · entry 1 Napolitano Richard J · CIK 0001599417 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,814 F1 · shares: Represents shares reacquired by MSCI Inc. to satisfy tax withholding obligations in connection with the vesting and conversion to shares of 685 performance stock units related to the achievement of certain cumulative performance metrics for the 2014 and 2015 fiscal years that time-vested on December 31, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.